• Entertainment
  • Finance
  • Marketing
  • Real Estate
  • Technology
  • Social
National Journal Community Of e-Experts
Finance 0

Biotechs Stalled And Get No Help From Monday’s Market Moves

By Kurt Osterberg · On April 17, 2018

Biotechs Stalled Despite Healthcare Rally

Merck Gains on New Keytruda Data-More Clinical Trials Underway to Expand Uses

Healthcare and Nasdaq stocks caught bids on Monday with the XLV up 0.79%, but biotechs were in the red (IBB) down 0.68 %. Drug distributors and drugstores rallied on news that Amazon(AMZNAmazon(  to sell drugs to hospitals and other businesses. CVS Health (CVS) was up 4.2%, Cardinal Health (CAH) up 3.1%, McKesson (MCK) up 3.1%  and United Health (UNH) up 2.9%, as this sector recovered from a big hit in February.

Large cap biopharma stocks we’re mixed even though data on expensive immunotherapy drugs for lung cancer showed improved survival with investors betting that Merck’s Keytruda would do better than Opdivo from Bristol-Myers Squibb. 2017 sales for Keytruda topped $3.8B in 2017. Survival rates for lung cancer (~20%) still lag many other cancers. Merck (MRK) was up 2.6% while Bristol-Myers Squibb (BMY) was down 7.79%.

Abbvie (ABBV) was up 0.84% and Celgene (CELG) held the $90 level up 1.28%.

Large cap investors can add Merck (MRK) with potential gains ahead and a 3.38% dividend. As we await Q1 earnings we can better forecast winners among the large caps.

Mid-cap biopharma stocks were mainly losers except  Alkermes (ALKS) up 4.47% and Tesaro (TSRO) up 6.22%. Clovis Oncology (CLVS) sunk 10.27% to $54.41 on news of proposed  offerings of convertible senior notes and stock.

The American Association for Cancer Research (AACR) Meeting takes place in Chicago this week so we can expect more clinical updates.

 

Print Friendly, PDF & Email

Share Tweet

Kurt Osterberg

You Might Also Like

  • Finance

    How Effective Is Virtual Training?

  • Finance

    Building Better Business Relationships: Your 3 Essential Mindsets

  • Finance

    Artificial Intelligence vs. Genuine Creativity

No Comments

Leave a reply Cancel reply

Top Finance

  • Chart: Amazon’s Dominance In Ecommerce Chart: Amazon’s Dominance In Ecommerce
  • Shark Tank Recap: Shed Defender, Tata Towels and Sanaia Applesauce Secure Deals Shark Tank Recap: Shed Defender, Tata Towels and Sanaia Applesauce Secure Deals
  • Hedge Funds In The US Hedge Funds In The US
  • One Ring To Rule Them All One Ring To Rule Them All
  • Dollar General (DG) Q2 Earnings And Revenues Surpass Estimates Dollar General (DG) Q2 Earnings And Revenues Surpass Estimates

New Posts

  • How Effective Is Virtual Training?

    How Effective Is Virtual Training?

    January 21, 2021
  • Building Better Business Relationships: Your 3 Essential Mindsets

    Building Better Business Relationships: Your 3 Essential Mindsets

    January 21, 2021
  • Artificial Intelligence vs. Genuine Creativity

    Artificial Intelligence vs. Genuine Creativity

    January 21, 2021
  • 3 Ways to Make 2021 a Great Year For Your Business

    3 Ways to Make 2021 a Great Year For Your Business

    January 21, 2021
  • 4 Automated Systems to Scale Your Business

    4 Automated Systems to Scale Your Business

    January 21, 2021
  • About
  • Contact Us
  • Privacy & Policy
  • Sitemap
  • Terms of use

Copyright © 2018 NJCEE. All Rights Reserved.